Physician profile
Benjamin Feibel
NPI 1114380656
$11,788.10
in general payments reported to CMS, 2019-2025
19 companies · $2,754 in 2025
The $2,754 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,307 · 2022: $1,104 · 2023: $3,684 · 2024: $1,940 · 2025: $2,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,765 · Travel and Lodging: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,764.60 |
| Travel and Lodging | $1,613.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,861.57 | 2021-2025 | Mako, Insignia, Accolade |
| Zimmer Biomet Holdings, INC. | $1,145.04 | 2022-2024 | Persona, Osseotite |
| Vericel Corporation | $187.48 | 2021-2023 | Maci |
| Curonix LLC | $123.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $73.97 | 2022-2023 | Seglentis |
| Solventum Corporation | $50.21 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Medtronic, INC. | $41.52 | 2025 | Aquamantys(Tm) |
| Biocomposites INC | $39.67 | 2025 | Stimulan |
| Nalu Medical, INC. | $39.20 | 2025 | Nalu Neurostimulation System |
| Dynasplint Systems INC. | $37.50 | 2023 | Dynasplint |
| Davol INC. | $31.22 | 2025 | Arista |
| Si-Bone, INC. | $31.12 | 2021 | |
| Abbott Laboratories | $22.70 | 2025 | Eterna |
| Vertex Pharmaceuticals Incorporated | $21.02 | 2025 | |
| Depuy Synthes Sales INC. | $20.38 | 2023 | Motoband, Tfn-Advance, Na |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $19.72 | 2024 | Irrisept |
| Axogen | $14.28 | 2021 | |
| Sanara Medtech INC. | $13.94 | 2022 | |
| Amgen INC. | $13.85 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Feibel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.